LAB Standard BioTools Inc.
$0.62▲ +2.68%
Healthcare
Other
After hours
$0.62▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.04M
Avg Volume (10D) 676.2K
Key Metrics & Fundamentals
Market Cap
$243.18M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.59 - 1.72
% vs 50 MA
-9.78%
% vs 200 MA
-33.75%
RSI-14
38.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.10
Free Cash Flow
-$10.66M
Gross Rev
$20.10M
Gross Profit
$10.54M
EBITDA
$11.00M
COGS
$9.57M
Operating Exp
$18.36M
Operating Income
-$7.83M
EBIT
-$7.83M
Pretax Income
-$21.44M
Net Income
-$26.76M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Standard BioTools Provides Update on Sale of Mass Cytometry Business
GlobeNewswire · Sep 30, 2026 4:42 PM ET
Standard BioTools: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 4:25 PM ET
Standard BioTools Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 5, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LAB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.